Client News

Verona Pharma plc: Verona Pharma to Present Phase 2b COPD Symptom and Quality of Life Data with Ensifentrine at CHEST 2020

Abivax secures EUR 15m non-dilutive financing from Kreos Capital

Secarna Pharmaceuticals and Denali Therapeutics enter into research and option agreement to develop novel antisense therapies in the field of neurodegenerative diseases

Rentschler Biopharma SE: Joining forces against SARS-CoV-2: Rentschler Biopharma contributes to manufacturing of COVID-19 mRNA vaccine

Paion AG reports progress with BYFAVO(TM) (remimazolam) by its licensee Acacia in the U.S.

ECBF Management GmbH: Introduction of the new European Circular Bioeconomy Fund

CENTOGENE’s Information Security Management System Awarded ISO/IEC 27001:2017 Accreditation

THE LANCET publishes promising data of APEIRON’s APN01 (rhsACE2) to treat COVID-19 in named patient use

avateramedical GmbH: German medical technology company avateramedical N.V. appoints Ian Read, former Chairman and CEO of Pfizer, to the Board

Abivax presents first-half 2020 financial results and operations update